Related by context. Frequent words. (Click for all words.) 85 Drug Candidate 83 Phase III Clinical Trial 83 Patient Enrollment 82 Clinical Trial Results 82 Completes Enrollment 81 II Clinical Trial 81 Preclinical Data 81 Phase III Trial 80 Single Dose 80 Initiate Phase 79 Presents Positive 79 Pivotal Phase 79 FDA Accepts 78 Well Tolerated 78 Pivotal Phase III 78 Metastatic Melanoma 77 Pivotal Study 77 Initiates Phase 76 FDA Clears 75 Pivotal Trial 75 Elderly Patients 75 Chronic Hepatitis C 75 Advanced Prostate Cancer 75 Monoclonal Antibody 75 Tumor Growth 75 Recombinant Human 74 Prostate Cancer Patients 74 Pediatric Patients 74 Generic Version 74 Monotherapy 74 Diabetic Patients 74 Pulmonary Arterial Hypertension 74 Chronic Hepatitis B 73 Epratuzumab 73 Develop Novel 73 Study Demonstrates 73 Patients Treated 73 Anti Inflammatory 73 Overactive Bladder 73 Significantly Reduces 73 Aliskiren 73 Drug Resistant 73 Heart Failure Patients 73 Metastatic Colorectal Cancer 72 Reduces Risk 72 Combination Therapy 72 Panzem R 72 Small Molecule 72 Allergic Rhinitis 72 Smallpox Vaccine 71 Gene Mutation 71 Benign Prostatic Hyperplasia 71 Cholesterol Drug 71 MKC# 71 Cethromycin 71 RNAi Therapeutics 71 Autoimmune Diseases 71 J Am Coll 71 Newly Diagnosed 71 Atopic Dermatitis 71 Extended Release 71 Patients Undergoing 71 Postmenopausal Women 71 Receives FDA Clearance 71 Inhibits 71 Insulin Resistance 70 Malaria Vaccine 70 Stomach Cancer 70 Patent Covering 70 Meta Analysis 70 Bortezomib 70 Increases Risk 70 Shows Promise 70 Dasatinib 70 Low Dose 70 Lung Cancer Patients 70 FDA Approves 70 Announces Initiation 69 Increased Risk 69 Denufosol 69 Induces 69 Autoimmune Disease 69 refractory chronic lymphocytic 69 Golimumab 69 Generalized Anxiety Disorder 69 Daclizumab 69 Chronic Heart Failure 69 Holds Promise 69 Cardiovascular Events 69 Diabetic Macular Edema 69 Tolerability 69 Voreloxin 69 Cancer Treatments 69 Transcept Pharmaceuticals 69 Breast Cancer Patients 69 Blood Thinner 69 Gastric Cancer 69 Gum Disease 69 Urinary Tract Infections 68 FDA Clearance 68 PEG SN#